BTIG Analyst Reiterates Hold Rating on BioNano Genomics (BNGO)

BioNano Genomics received a Hold rating from BTIG analyst Mark Massaro, citing the company's shares closed at $4.13. Massaro has a success rate of 31.13% on recommended stocks. BioNano Genomics also received a Hold from TR | OpenAI – 4o's Cira Diagnissa, but a Buy rating from Maxim Group. The company's market cap is $15.31M and P/E ratio is -0.08.

Bionano Genomics (NASDAQ: BNGO), a biotechnology company focused on life sciences tools and services, has been the subject of varying analyst ratings. On July 2, 2025, BTIG analyst Mark Massaro assigned a Hold rating to Bionano Genomics' stock, noting that the shares closed at $4.13. Massaro's success rate for recommended stocks stands at 31.13%, indicating a cautious approach to Bionano Genomics' stock.

In contrast, TR | OpenAI – 4o's Cira Diagnissa also issued a Hold rating for Bionano Genomics, while Maxim Group gave a Buy rating. These differing opinions highlight the varied perspectives among analysts on Bionano Genomics' potential.

The company's market capitalization is $15.31 million, and its price-to-earnings (P/E) ratio stands at -0.08, indicating that it is currently trading at a negative P/E ratio. This unusual P/E ratio suggests that the company is experiencing significant losses, which could impact its stock performance.

Bionano Genomics' stock has shown recent volatility, with a 52-week high of $33.72 and a 52-week low of $2.68. The stock's price has been above its 5, 20, and 50-day exponential moving averages, indicating a strongly bullish trend [1].

Despite the mixed analyst ratings, Bionano Genomics has shown growth potential. The company's revenue is forecast to grow at an average annual rate of 24% over the next three years, compared to a 6.0% growth forecast for the Life Sciences industry in the US [2].

Investors should carefully consider the risks associated with Bionano Genomics, as the company faces several challenges. Analysts have identified four warning signs, with two of them being particularly concerning [2].

References:
[1] https://financhill.com/stock-forecast/bngo-stock-prediction
[2] https://finance.yahoo.com/news/bionano-genomics-second-quarter-2025-142219941.html